Claros N - Search Results

1

Retinal angiogenesis suppression through small molecule activation of p53.

Chavala SH, Kim Y, Tudisco L, Cicatiello V, Milde T, Kerur N, Claros N, Yanni S, Guaiquil VH, Hauswirth WW, Penn JS, Rafii S, De Falco S, Lee TC, Ambati J. Chavala SH, et al. Among authors: claros n. J Clin Invest. 2013 Oct;123(10):4170-81. doi: 10.1172/JCI67315. Epub 2013 Sep 9. J Clin Invest. 2013. PMID: 24018558 Free PMC article.

2

Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells.

Elison JR, Cobrinik D, Claros N, Abramson DH, Lee TC. Elison JR, et al. Among authors: claros n. Arch Ophthalmol. 2006 Sep;124(9):1269-75. doi: 10.1001/archopht.124.9.1269. Arch Ophthalmol. 2006. PMID: 16966622

3

Cell cycle-specific and cell type-specific expression of Rb in the developing human retina.

Lee TC, Almeida D, Claros N, Abramson DH, Cobrinik D. Lee TC, et al. Among authors: claros n. Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5590-8. doi: 10.1167/iovs.06-0063. Invest Ophthalmol Vis Sci. 2006. PMID: 17122153

4

Pleiotropic stromal effects of vascular endothelial growth factor receptor 2 antibody therapy in renal cell carcinoma models.

Duignan IJ, Corcoran E, Pennello A, Plym MJ, Amatulli M, Claros N, Iacolina M, Youssoufian H, Witte L, Samakoglu S, Schwartz J, Surguladze D, Tonra JR. Duignan IJ, et al. Among authors: claros n. Neoplasia. 2011 Jan;13(1):49-59. doi: 10.1593/neo.101162. Neoplasia. 2011. PMID: 21245940 Free PMC article.

5

Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in mice.

Surguladze D, Deevi D, Claros N, Corcoran E, Wang S, Plym MJ, Wu Y, Doody J, Mauro DJ, Witte L, Busam KJ, Pytowski B, Rodeck U, Tonra JR. Surguladze D, et al. Among authors: claros n. Cancer Res. 2009 Jul 15;69(14):5643-7. doi: 10.1158/0008-5472.CAN-09-0487. Epub 2009 Jul 7. Cancer Res. 2009. PMID: 19584274

6

Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjögren's syndrome.

Paranyuk Y, Claros N, Birzgalis A, Moore LC, Brink PR, Walcott B. Paranyuk Y, et al. Among authors: claros n. Curr Eye Res. 2001 Sep;23(3):199-205. doi: 10.1076/ceyr.23.3.199.5468. Curr Eye Res. 2001. PMID: 11803482

7

A model of fluid secretion by the acinar cells of the mouse lacrimal gland.

Walcott B, Moore L, Birzgalis A, Claros N, Brink PR. Walcott B, et al. Among authors: claros n. Adv Exp Med Biol. 2002;506(Pt A):191-7. doi: 10.1007/978-1-4615-0717-8_25. Adv Exp Med Biol. 2002. PMID: 12613907 No abstract available.

8

Age-related decrease in innervation density of the lacrimal gland in mouse models of Sjögren's syndrome.

Walcott B, Claros N, Patel A, Brink PR. Walcott B, et al. Among authors: claros n. Adv Exp Med Biol. 1998;438:917-23. doi: 10.1007/978-1-4615-5359-5_130. Adv Exp Med Biol. 1998. PMID: 9634988 No abstract available.

9

Cholinergic modulation of immunoglobulin secretion from avian plasma cells: the role of cyclic mononucleotides.

Cameron RH, Walcott B, Claros N, Mendel K, Brink PR. Cameron RH, et al. Among authors: claros n. J Neuroimmunol. 1995 Sep;61(2):223-30. doi: 10.1016/0165-5728(95)00095-j. J Neuroimmunol. 1995. PMID: 7593558

10

Role of gap junctions in fluid secretion of lacrimal glands.

Walcott B, Moore LC, Birzgalis A, Claros N, Valiunas V, Ott T, Willecke K, Brink PR. Walcott B, et al. Among authors: claros n. Am J Physiol Cell Physiol. 2002 Mar;282(3):C501-7. doi: 10.1152/ajpcell.00004.2001. Am J Physiol Cell Physiol. 2002. PMID: 11832335 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters